Group 1 - Rathbones Group Plc disclosed interests in relevant securities representing 1% or more under Rule 8.3 of the Takeover Code [1][17] - The disclosure relates to a consortium comprising LondonMetric Property plc and Schroder Real Estate Investment Trust Limited [1][17] - The date of the position held was 31/03/2026 [1][17] Group 2 - Rathbones Group Plc holds 85,428,649 shares in LondonMetric Property plc, representing 3.64% of the relevant securities [3][19] - The company also holds 19,883,983 shares in Schroder Real Estate Investment Trust, representing 4.06% of the relevant securities [4][19] Group 3 - Recent dealings include multiple sales and purchases of LondonMetric 10p Ordinary Shares, with sales totaling 28,967 shares at 179.0799p and purchases totaling 41,000 shares at 178.29p [8][23][24] - The total number of shares sold and purchased indicates active trading in LondonMetric shares [8][23][24]

Core Viewpoint - Nike's shares experienced a significant decline in after-hours trading due to a warning about a decrease in current-quarter revenue, highlighting ongoing challenges in the crucial China market and an inconsistent recovery [1] Group 1: Revenue Outlook - The company anticipates a decline in revenue for the current quarter, indicating potential financial difficulties ahead [1] - This forecast reflects the ongoing struggles in the Chinese market, which is a key area for Nike's sales [1] Group 2: Market Challenges - Persistent challenges in the China market are affecting Nike's overall performance, suggesting that the company may need to reassess its strategies in this region [1] - The uneven turnaround in business operations indicates that recovery efforts may not be yielding the expected results [1]

Group 1 - Dianthus Therapeutics, Inc. (DNTH) shares increased by 5.6% to close at $83.92, with a significant trading volume compared to normal sessions, and a total gain of 43.8% over the past four weeks [1][2] - The rise in share price is linked to positive investor sentiment regarding the company's pipeline, particularly following an early "GO" decision in the late-stage CAPTIVATE study for claseprubart, aimed at treating chronic inflammatory demyelinating polyneuropathy (CIDP) [2] - The stock received further support after the FDA approved several proposed changes to the clinical development of claseprubart, affecting all ongoing and future studies [3] Group 2 - The company is projected to report a quarterly loss of $1.17 per share, reflecting a year-over-year decline of 42.7%, with expected revenues of $0.55 million, down 53% from the previous year [4] - The consensus EPS estimate for the quarter has been revised down by 27.6% over the last 30 days, indicating a negative trend in earnings estimate revisions, which typically does not lead to price appreciation [5] - Dianthus Therapeutics, Inc. holds a Zacks Rank of 3 (Hold), indicating a neutral outlook, while another company in the same industry, Foghorn Therapeutics Inc. (FHTX), has also experienced a decline in stock performance [6]

Core Viewpoint - U.S. stock futures and global markets are experiencing a surge due to optimism surrounding a potential resolution to the Iran war, following President Trump's announcement of a planned withdrawal of American forces within two to three weeks [1][2]. Market Performance - In early trading, the Dow Futures index increased by 0.43% to 46,780 points, while the S&P 500 Futures rose by 0.5% to 6,604 points, continuing a rally that saw both indexes rise by 2.5% on Tuesday [1]. - The tech-centric Nasdaq futures climbed to 24,092.50 points, reflecting a 0.75% increase from Tuesday's close [2]. - Asian markets showed significant gains, with Japan's Nikkei 225 surging by 5.24% and South Korea's KOSPI jumping by 8.44%. Other indices, such as Hong Kong's Hang Seng and India's Sensex, rose by 1.91% and 2.27%, respectively [2]. - European markets also experienced sharp increases, with the pan-European STOXX Europe 50 rising by 2% and the London Stock Exchange's FTSE 100 increasing by 1.3% [3]. Oil Prices - The optimism regarding a swift resolution to the Iran conflict has led to a notable impact on oil prices, with the global benchmark Brent Crude Index briefly falling below $100 per barrel. As of the report, Brent Crude Futures contracts for June were priced at $101.67 per barrel, while the now-expired May contracts had risen to nearly $120 per barrel due to ongoing tensions in the Persian Gulf [4].

Core Insights - Tarkett has achieved a 27% reduction in greenhouse gas emissions across its entire value chain, aligning with its 2030 sustainability goals [2] - The company has doubled the average proportion of recycled materials in its products from 10% in 2018 to 20% in 2025, with a target of reaching 30% by 2030 [2][4] - Tarkett's net sales reached €3.3 billion in 2025, with a workforce of 12,000 employees and operations in over 100 countries [4] Sustainability Progress - Tarkett's sustainability roadmap has seen significant advancements, including the deployment of its ReStart® take-back and recycling program in 29 countries [4] - The company has collected 129,000 tons of end-of-life flooring over the past 16 years, equivalent to 12 Eiffel Towers [4] - In 2025, Tarkett recovered 86,000 m² of end-of-life vinyl flooring from IKEA stores, avoiding 1,000 tons of greenhouse gas emissions [4] Energy and Resource Management - 43% of Tarkett's energy consumption comes from renewable sources, with 16 plants purchasing 100% renewable electricity [4] - The use of wood dust as biomass for energy production at six plants has led to a reduction of 12.4ktCO₂e, equivalent to removing 6,500 passenger cars from the road for a year [4] Circular Economy Initiatives - Tarkett has developed a reuse offer for second-hand carpet tiles, collecting 9,000 m² of old carpets in 2025, with 2,000 m² sent for recycling and 7,000 m² for reuse [4] - The company's infill regeneration facilities in Pennsylvania and Oregon collected and recovered 14,100 tons of infill for reuse in new projects in 2025, marking a 21% increase from 2024 [4] Diversity and Inclusion - The share of women in management positions at Tarkett has reached 29%, progressing towards a global goal of 33% by 2030 [4]

Market Opportunity - Light-duty vehicles in the U.S. travel over 3 trillion miles annually, with ride-sharing services charging $1 to $2 per mile, indicating a potential trillion-dollar market for robotaxis in the U.S. alone [1] Nvidia - Ken Griffin's hedge fund has significant holdings in Nvidia, which is the industry standard for AI workload acceleration through its GPUs, essential for developing robotaxis [2][4] - Nvidia's software ecosystem, including code libraries and pretrained models, facilitates the development of autonomous driving systems [5] - The integration of Nvidia's tools, such as Omniverse for simulation and Cosmos for generating synthetic data, enhances the training of AI models for autonomous vehicles [6][8] - Nvidia's CFO stated that robotaxis could generate hundreds of billions in revenue over the next decade, with every major OEM utilizing Nvidia technology [8][9] - Wall Street estimates Nvidia's earnings will grow at 38% annually over the next three years, making its current valuation of 35 times earnings appear attractive [9] Amazon - Amazon's second-largest holding is Zoox, which operates purpose-built robotaxis without traditional driving controls, currently providing rides in Las Vegas and San Francisco [10][11] - Zoox is testing robotaxis in Austin and plans to expand its service area, having applied for a commercial ride-sharing service with up to 2,500 vehicles [12] - Morgan Stanley projects Zoox will account for 12% of autonomous rides annually by 2032, positioning it behind major competitors like Waymo, Tesla, and Uber [13] - Amazon's core businesses, including e-commerce and cloud computing, are expected to see earnings growth of 19% annually over the next three years, with a current valuation of 29 times earnings being attractive [14]

Core Insights - Novo Nordisk's stock rose by as much as 4% following a recommendation from England's drug price regulator to use its drug Wegovy for preventing heart attacks and strokes [1] - The recommendation from the National Institute for Health and Care Excellence (NICE) will significantly increase access to Wegovy through the National Health Service (NHS) in England [2] - NICE has recommended semaglutide, the active ingredient in Wegovy, for adults with a BMI of at least 27 who have a history of heart attack, stroke, or serious circulation issues [3] Group 1 - Novo Nordisk's shares were observed to be up 2% in morning trading, reflecting a positive market response [3] - The broader market, represented by the pan-European blue-chip index Stoxx 600, also saw an increase of 2.1% [3]

Core Insights - Baidu's Apollo Go robotaxis experienced a malfunction, leading to vehicles stalling mid-traffic in Wuhan, causing highway collisions [1][2] - The Wuhan local traffic police confirmed the incident, attributing it to system malfunctions and stating that passengers were safely evacuated [2][3] - Apollo Go operates the largest robotaxi deployment in China, with over 1,000 vehicles functioning without human drivers in Wuhan [3] Company Developments - Baidu has significantly invested in its driverless ride-hailing unit, paralleling Alphabet's investment in its Waymo robotaxi service [4] - Apollo Go is currently providing commercial driverless ride-hailing services in major Chinese cities, including Wuhan and suburban Beijing [6] - As of the fourth quarter of 2025, Apollo Go's driverless vehicles are deployed or being tested in 26 international cities [6] Competitive Landscape - Apollo Go faces competition from other Chinese autonomous vehicle manufacturers such as WeRide and Pony.AI [5] - Tesla is also developing driverless vehicles but has not yet launched a commercial robotaxi service outside of a limited pilot in Austin, Texas [5]

Core Viewpoint - Both President Donald Trump and Iranian President Masoud Pezeshkian indicated that the ongoing conflict may reach a resolution soon [1] Group 1 - The statements from both leaders suggest a potential shift in diplomatic relations [1] - The optimism expressed by the leaders could impact market sentiments and investor confidence in the region [1]

Core Viewpoint - The content emphasizes the importance of conducting personal due diligence and consulting with competent advisors before making any financial decisions, particularly in relation to investments in complex instruments like cryptocurrencies and CFDs [1]. Group 1 - The website provides general news, personal analysis, and third-party materials intended for educational and research purposes [1]. - It explicitly states that the information should not be interpreted as a recommendation or advice for investment actions [1]. - The accuracy and reliability of the information are not guaranteed, and users are cautioned against relying solely on the content provided [1]. Group 2 - The website discusses the high risks associated with cryptocurrencies and CFDs, highlighting that they are complex instruments with a significant potential for financial loss [1]. - It encourages users to conduct their own research and fully understand the workings and risks of any financial instruments before investing [1].